Chiron Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-54,265
Closed -$6.72M 106
2024
Q2
$6.72M Buy
+54,265
New +$6.99M 2.64% 16
2023
Q4
Sell
-107,351
Closed -$11.1M 100
2023
Q3
$11.1M Buy
107,351
+73,700
+219% +$7.94M 4.67% 6
2023
Q2
$3.88M Buy
+33,651
New +$3.82M 1.09% 27
2017
Q2
Sell
-83,211
Closed -$5.04M 39
2017
Q1
$5.04M Buy
+83,211
New +$5.05M 1.92% 23

Other funds holding MRK

Chiron Investment Management's MRK Position: Q3 2024 in Review

Chiron Investment Management sold out of Merck (MRK) in Q3 2024, closing a stake of 54,265 shares — an estimated $6.72M sold.

Chiron Investment Management first reported a position in MRK in Q1 2017 and held it in 4 quarters. The position peaked at $11.1M in Q3 2023. 3,489 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • Chiron Investment Management reported no remaining Merck position as of Q3 2024 after selling out during the quarter.
  • Chiron Investment Management sold 54,265 Merck shares in Q3 2024, an estimated $6.72M.
  • Chiron Investment Management first reported a position in Merck in Q1 2017 and held it in 4 quarters.
  • Chiron Investment Management's Merck position peaked at $11.1M in Q3 2023.
  • 3,489 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Chiron Investment Management's 13F filing for Q3 2024, filed 18 Nov 2024.